NIH launches QuSAFE, a $7.1 million challenge for quantum sensors in drug safety testing

Started by Silas90, Today at 08:10 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

Topic: NIH launches QuSAFE, a $7.1 million challenge for quantum sensors in drug safety testing   Views(Read 17 times)
Active members in this topic:
Silas90(1)

Silas90

Quantum World Congress has a piece on the US National Institutes of Health wanting quantum sensors to make drug testing more human. The programme behind it is a prize competition called QuSAFE. Quantum Zeitgeist reports that it will distribute $7.1 million across several stages, with a grand prize of $840,000. The aim is to use quantum sensing to improve lab based alternatives to animal testing

These alternatives are known as new approach methodologies, and they include organ on chip platforms, where human cells are grown in tiny devices that mimic how real organs behave. They have huge potential, but current tools cannot always detect the subtle biological signals needed to judge whether a drug is safe. QuSAFE wants quantum sensors that can pick up those signals. If it works, drug testing could become both more accurate for humans and less reliant on animals. Animal models do not always predict how human bodies will respond

The technologies listed include nanodiamond sensors that measure temperature inside cells, quantum magnetometers that track electrical activity in tissue and quantum enhanced spectroscopy for metabolism. Hybrid quantum and classical approaches are also welcome. Nanodiamonds are the same nitrogen vacancy technology behind the Melbourne diamond hub we covered this week. It is one of the more practical uses of quantum tech outside computing

The structure is flexible. Stage 1 offers $500,000 split between up to 25 winners for concept proposals, and Stage 2 provides $6.6 million for prototypes, with six finalists receiving $460,000 each. Teams with existing hardware can skip straight to Stage 2. Registration opens on 25 October, and NASA, NSF and other federal bodies are supporting the effort. That flexibility should attract teams at different stages

I am keeping this to the technology side rather than medical advice. Reducing animal testing while making drug safety checks more reliable sounds like a win on both counts. Do you think quantum sensing will reach real labs before quantum computing does? And how close are organ on chip systems to replacing animal tests?